Cargando…
Targeting the Orexin System for Prescription Opioid Use Disorder
Prescription opioids are potent analgesics that are used for clinical pain management. However, the nonmedical use of these medications has emerged as a major concern because of dramatic increases in abuse and overdose. Therefore, effective strategies to prevent prescription opioid use disorder are...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225970/ https://www.ncbi.nlm.nih.gov/pubmed/32290110 http://dx.doi.org/10.3390/brainsci10040226 |
_version_ | 1783534177520451584 |
---|---|
author | Matzeu, Alessandra Martin-Fardon, Rémi |
author_facet | Matzeu, Alessandra Martin-Fardon, Rémi |
author_sort | Matzeu, Alessandra |
collection | PubMed |
description | Prescription opioids are potent analgesics that are used for clinical pain management. However, the nonmedical use of these medications has emerged as a major concern because of dramatic increases in abuse and overdose. Therefore, effective strategies to prevent prescription opioid use disorder are urgently needed. The orexin system has been implicated in the regulation of motivation, arousal, and stress, making this system a promising target for the treatment of substance use disorder. This review discusses recent preclinical studies that suggest that orexin receptor blockade could be beneficial for the treatment of prescription opioid use disorder. |
format | Online Article Text |
id | pubmed-7225970 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72259702020-05-18 Targeting the Orexin System for Prescription Opioid Use Disorder Matzeu, Alessandra Martin-Fardon, Rémi Brain Sci Review Prescription opioids are potent analgesics that are used for clinical pain management. However, the nonmedical use of these medications has emerged as a major concern because of dramatic increases in abuse and overdose. Therefore, effective strategies to prevent prescription opioid use disorder are urgently needed. The orexin system has been implicated in the regulation of motivation, arousal, and stress, making this system a promising target for the treatment of substance use disorder. This review discusses recent preclinical studies that suggest that orexin receptor blockade could be beneficial for the treatment of prescription opioid use disorder. MDPI 2020-04-10 /pmc/articles/PMC7225970/ /pubmed/32290110 http://dx.doi.org/10.3390/brainsci10040226 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Matzeu, Alessandra Martin-Fardon, Rémi Targeting the Orexin System for Prescription Opioid Use Disorder |
title | Targeting the Orexin System for Prescription Opioid Use Disorder |
title_full | Targeting the Orexin System for Prescription Opioid Use Disorder |
title_fullStr | Targeting the Orexin System for Prescription Opioid Use Disorder |
title_full_unstemmed | Targeting the Orexin System for Prescription Opioid Use Disorder |
title_short | Targeting the Orexin System for Prescription Opioid Use Disorder |
title_sort | targeting the orexin system for prescription opioid use disorder |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225970/ https://www.ncbi.nlm.nih.gov/pubmed/32290110 http://dx.doi.org/10.3390/brainsci10040226 |
work_keys_str_mv | AT matzeualessandra targetingtheorexinsystemforprescriptionopioidusedisorder AT martinfardonremi targetingtheorexinsystemforprescriptionopioidusedisorder |